cbdMD (YCBD) Cash from Financing Activities (2016 - 2025)

cbdMD has disclosed Cash from Financing Activities across 10 years of filings, most recently posting $2.1 million for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $2.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.5 million (up 173.01% YoY), and the FY2025 annual result was $1.4 million, up 11.39% from the prior year.
• Cash from Financing Activities came in at $2.1 million for Q4 2025 at cbdMD, up from $1.4 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $13.8 million in Q3 2021 to a low of -$1.1 million in Q4 2022.
• The 5-year median for Cash from Financing Activities is -$619751.0 (2021), against an average of $752267.8.
• Across the five-year window, Cash from Financing Activities plunged 142.35% in 2021 and jumped 144523500.0% in 2025, its largest moves.
• cbdMD's Cash from Financing Activities stood at -$1.0 million in 2021, then declined by 10.92% to -$1.1 million in 2022, then surged by 99.78% to -$2501.0 in 2023, then jumped by 100.04% to $1.0 in 2024, then jumped by 210395600.0% to $2.1 million in 2025.
• The last three Cash from Financing Activities figures came in at $2.1 million (Q4 2025), $1.4 million (Q3 2025), and $1.0 (Q3 2024), per Business Quant data.